A Bradford researcher has discovered a potential new drug which could tackle an aggressive type of breast cancer.
Professor Mohamed El-Tanani from the University of Bradford’s Institute for Cancer Therapeutics has been working with colleagues from Ulster University, Sunderland and Queen’s University Belfast to come up with this new drug that attacks cancer cells.
Laboratory tests have shown when the drug is added to hard-to-treat breast cancer cells, the cells actively take it in and their growth rate is reduced.
Professor El-Tanani has said: “By developing a nanoparticle that can help this peptide enter triple negative breast cancer cells and block RAN we’ve brought this potential new treatment a step closer to the clinic.”
Leeds Man Jailed for 12 Years After Horrific Campaign of Domestic Abuse
MK’s Most Popular Library Expands with Flexible Spaces for All
West Yorkshire Police Officer Charged with Sexual Assault
Millions of Tenants Protected Under New Awaab’s Law Reforms
Bradford Expands ‘New York’ Style Housing First Approach to Tackle Homelessness
Kensington Palace Marks 150th Birthday of Punjabi Princess and Suffragette Sophia Duleep Singh
SENDIVERSE Festival Unites Bradford Through Creativity and Inclusion
Appeal After Man Seriously Injured in Burnley Collision
Multibillion Economic Vision for Leeds to Create 100,000 Jobs
Building at Bradford Royal Infirmary Renamed in Honour of Renowned Surgeon
Airedale Nurse Shortlisted for National Neonatal Award
The Golden Era
Bhangra Nights
Legal Show
Alim OnAir